Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib
afatinib
1200.33
NCT00711594
Carcinoma, Non-Small-Cell Lung
Phase 2
 
July 2014

Powered by ideaPoint, Inc.